Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Nov;12(5):625–629. doi: 10.1128/aac.12.5.625

Lack of Effect of Methenamine in Suppression of, or Prophylaxis Against, Chronic Urinary Infection

Bernardo Vainrub 1,2, Daniel M Musher 1,2
PMCID: PMC429988  PMID: 921259

Abstract

Methenamine is frequently prescribed for patients who have chronic urinary infection to suppress bacterial growth during active infection or to prevent recurrence once an infection has been brought under control. We have examined the effect of methenamine mandelate and ascorbic acid on bacteriuria in para- and quadriplegics from a spinal cord unit. Patients with indwelling urinary catheters and those on a program of intermittent catheterization were included. No suppressive or prophylactic effect of this regimen was observed in any of our patients. Methenamine does not appear to be an effective antimicrobial agent in subjects who have an indwelling urinary catheter or in patients with spinal cord injury who are on intermittent catheterization. Since there appears to be reason to question the efficacy of methenamine in situations in which it is usually prescribed, evidence should be sought for a therapeutic effect in other cases. If no benefit is observed, the drug should not be used.

Full text

PDF
625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Freeman R. B., Bromer L., Brancato F., Cohen S. I., Garfield C. F., Griep R. J., Hinman E. J., Richardson J. A., Thurm R. H., Urner C. Prevention of recurrent bacteriuria with continuous chemotherapy. Ann Intern Med. 1968 Oct;69(4):655–672. doi: 10.7326/0003-4819-69-4-655. [DOI] [PubMed] [Google Scholar]
  2. Gerstein A. R., Okun R., Gonick H. C., Wilner H. I., Kleeman C. R., Maxwell M. H. The prolonged use of methenamine hippurate in the treatment of chronic urinary tract infection. J Urol. 1968 Dec;100(6):767–771. doi: 10.1016/s0022-5347(17)62622-3. [DOI] [PubMed] [Google Scholar]
  3. HOLLAND N. H., WEST C. D. Prevention of recurrent urinary tract infections in girls. Am J Dis Child. 1963 Jun;105:560–567. doi: 10.1001/archpedi.1963.02080040562006. [DOI] [PubMed] [Google Scholar]
  4. Harding G. K., Ronald A. R. A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women. N Engl J Med. 1974 Sep 19;291(12):597–601. doi: 10.1056/NEJM197409192911203. [DOI] [PubMed] [Google Scholar]
  5. Kasanen A., Mustakallio E., Koskinen E. H., Soini V. Methenamine hippurate in the treatment of urinary tract infections. Ann Clin Res. 1974 Oct;6(5):279–284. [PubMed] [Google Scholar]
  6. Miller H., Phillips E. Antibacterial correlates of urine drug levels of hexamethylenetetramine and formaldehyde. Invest Urol. 1970 Jul;8(1):21–33. [PubMed] [Google Scholar]
  7. Musher D. M., Griffith D. P. Generation of formaldehyde from methenamine: effect of pH and concentration, and antibacterial effect. Antimicrob Agents Chemother. 1974 Dec;6(6):708–711. doi: 10.1128/aac.6.6.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Musher D. M., Griffith D. P., Richie Y. The generation of formaldehyde from methenamine. Effect of urinary flow and residual volume. Invest Urol. 1976 Mar;13(5):380–382. [PubMed] [Google Scholar]
  9. Musher D. M., Thorsteinsson S. B., Airola VM I. I. Quantitative urinalysis. Diagnosing urinary tract infection in men. JAMA. 1976 Nov 1;236(18):2069–2072. doi: 10.1001/jama.236.18.2069. [DOI] [PubMed] [Google Scholar]
  10. Seneca H., Zinsser H. H., Peer P. Chemotherapy of chronic urinary tract infections with methenamine hippurate. J Urol. 1967 Jun;97(6):1094–1098. doi: 10.1016/S0022-5347(17)63184-7. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES